2012
DOI: 10.1016/j.apradiso.2012.07.009
|View full text |Cite
|
Sign up to set email alerts
|

The production, separation, and use of 67Cu for radioimmunotherapy: A review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
63
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 82 publications
(63 citation statements)
references
References 26 publications
0
63
0
Order By: Relevance
“…emitter 64 Cu. Its decay data are well known and the production methods have been recently reviewed [42]. Some of the reaction data have also been evaluated [14].…”
Section: Cumentioning
confidence: 99%
“…emitter 64 Cu. Its decay data are well known and the production methods have been recently reviewed [42]. Some of the reaction data have also been evaluated [14].…”
Section: Cumentioning
confidence: 99%
“…This isotope is useful for both therapeutic and diagnostic standpoints due to its medium energy beta particle, gamma emissions and 2.6-day half-life (15). 67 Cu is also used as a therapeutic nuclide for radioimmunotherapy (16). 67 Cu and 177 Lu are used particularly in radioimmunotherapy for the effective treatment of human ovarian cancer xenografts (17).…”
Section: Introductionmentioning
confidence: 99%
“…The article was found to contain a substantial amount of material from the following published articles:Szymański et al [2], which is cited as reference [4].Wadas et al [3], which is cited as reference [3].Carolyn and Ferdani [4], which is cited as reference [54].Smith et al [5], which is cited as reference [34].…”
mentioning
confidence: 99%